Zika virus is a rapidly emerging vector-born flavivirus, with potential to spread to new areas where the vector Aedes mosquitos are present.
The aim of the website, developed by the International Severe Acute Respiratory and Infection Consortium (ISARIC) and hosted by the Global Health Network (tGHN), is to provide a platform for sharing and developing research priorities, protocols and data capture systems alongside the latest epidemiological and clinical management information about Zika infection.
[Photo: Prof. Frank Hadley Collins, Dir., Cntr. for Global Health and Infectious Diseases, Univ. of Notre Dame, CDC. Aedes Aegypti mosquito feeding.]
The Oxford University Science Blog features a Q&A with Professor Trudie Lang, who heads the Global Health Network. The interview discusses why it is important to build research capacity in places where research doesn't normally happen, and how the response to Zika outbreak has learnt from the Ebola clinical trials.
Melioidosis, a difficult to diagnose deadly bacterial disease, is likely to be present in many more countries than previously thought, reports a paper published online today in the journal Nature Microbiology. The study predicts that melioidosis is present in 79 countries, including 34 that have never reported the disease.
On 14 Dec, Mr Gilles Garachon, the French Ambassador to Thailand, arrived at Mae Sot in Thailand to present France’s highest award, l'Ordre National de la Légion d’honneur, to Professor François Nosten, Head of MORU’s Shoklo Malaria Research Unit (SMRU). The award is in recognition of Professsor Nosten's work over three decades fighting malaria.
Researchers from the KEMRI Wellcome Trust programme in Kenya have uncovered some of the molecular processes through which some people appear to be naturally immune to malaria. Understanding these processes could help suggest new approaches to a malaria vaccine.
Dr Julie Makani has been recognized for her work on anaemia and sickle cell disease by the Planet Earth Institute, an international NGO and charity working for the scientific independent of Africa. Dr Makani was amongst the organization end-of-year list of the 'ten most inspirational people working in and passionate about science on the (African) continent.'
To coincide with the 2015 World Antibiotic Awareness Week, Professor Philip Guerin contributes to a series in The Lancet, examining whether the global fight against antimicrobial resistance is under threat.
A computer simulation study led by Professor Maciej Boni from the Oxford University Clinical Research Unit suggests that most effective way to save lives from malaria, while still limiting the spread of artemisinin-resistant parasites, is to simultaneously use non-artemisinin therapy amongst more effective artemisinin-based combinations.